Developing a new system for faster proton therapy treatment
A compact beam delivery system enabling ultra-fast dose delivery for upright proton therapy
This study is working on a new way to deliver proton therapy quickly and efficiently, especially for kids with cancer, so that treatments are faster and more comfortable for patients.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11045771 on NIH RePORTER |
What this research studies
This research focuses on creating a compact beam delivery system that uses advanced technology to enable ultra-fast dose delivery in proton therapy. By designing a novel energy degrader and a fixed beamline, the project aims to significantly reduce treatment times for patients, making proton therapy more efficient and accessible. The system is designed to accommodate moving targets, which is particularly beneficial for treating cancers in children. The ultimate goal is to enhance patient comfort and improve the overall quality of cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adolescents undergoing proton therapy for various types of cancer.
Not a fit: Patients who are not receiving proton therapy or those with conditions that do not require this specific treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective proton therapy treatments, improving outcomes for patients with cancer.
How similar studies have performed: Previous research has shown promise in enhancing proton therapy techniques, but this specific approach utilizing ultra-fast dose delivery is relatively novel.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Nesteruk, Konrad Pawel — Massachusetts General Hospital
- Study coordinator: Nesteruk, Konrad Pawel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.